Consultation responses

When government departments and other organisations want to introduce changes they usually ask the public what they think of their plans. This is called consultation.

Epilepsy Action frequently receives consultations and responds on behalf of people with epilepsy. As a membership organisation, we want to be everyone with an interest in our work to see exactly what we are saying on their behalf.

Below is a selection of responses that Epilepsy Action has sent to consultations where a response could benefit people living with epilepsy. It is worth checking this page regularly as new consultation responses will be listed here - please add this page to your bookmarks or favourites.

We are keen to get feedback on the responses that we have sent to consultations on behalf of people with epilepsy.

If you have any comments to make please contact Pete Scott, Epilepsy Action's Campaigns & Policy Officer, by phone on 0113 210 8800 or by email to pscott@epilepsy.org.uk

Consolidation and review of UK medicines legislation (MLX 375)

Submitted January 2012

In this consultation, we cautioned against a proposed change to regulations that would permit pharmacists to alter a prescription without consulting with its prescriber.

We do not oppose or object to the principle of pharmacists altering a prescription if it has an obvious error. However we raised a concern that they should only be altered when an error has clearly occurred.

We do not, for instance, believe that it would be appropriate for a pharmacist to alter a brand name or version of a drug, if a person has a history of receiving that version.

We asked the MHRA for clarification as to when it is or is not appropriate for a pharmacist to alter a prescription.

View the full response here.